Ekso Operating Cycle from 2010 to 2026

EKSO Stock  USD 8.02  0.10  1.26%   
Ekso Bionics Operating Cycle yearly trend continues to be very stable with very little volatility. Operating Cycle is likely to drop to 202.60. During the period from 2010 to 2026, Ekso Bionics Operating Cycle quarterly data regression pattern had sample variance of  10,880 and median of  263.60. View All Fundamentals
 
Operating Cycle  
First Reported
2010-12-31
Previous Quarter
311.11
Current Value
202.6
Quarterly Volatility
104.30938472
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Ekso Bionics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Ekso Bionics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.1 M, Interest Expense of 260.2 K or Selling General Administrative of 9.2 M, as well as many indicators such as Price To Sales Ratio of 11.24, Dividend Yield of 0.0076 or PTB Ratio of 15.86. Ekso financial statements analysis is a perfect complement when working with Ekso Bionics Valuation or Volatility modules.
  
Build AI portfolio with Ekso Stock
Check out the analysis of Ekso Bionics Correlation against competitors.

Latest Ekso Bionics' Operating Cycle Growth Pattern

Below is the plot of the Operating Cycle of Ekso Bionics Holdings over the last few years. It is Ekso Bionics' Operating Cycle historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Ekso Bionics' overall financial position and show how it may be relating to other accounts over time.
Operating Cycle10 Years Trend
Slightly volatile
   Operating Cycle   
       Timeline  

Ekso Operating Cycle Regression Statistics

Arithmetic Mean239.32
Geometric Mean214.92
Coefficient Of Variation43.59
Mean Deviation93.41
Median263.60
Standard Deviation104.31
Sample Variance10,880
Range317
R-Value0.73
Mean Square Error5,386
R-Squared0.54
Significance0.0008
Slope15.12
Total Sum of Squares174,087

Ekso Operating Cycle History

2026 202.6
2025 311.11
2024 345.68
2023 313.07
2022 413.4
2021 333.28
2020 328.66

About Ekso Bionics Financial Statements

Ekso Bionics investors utilize fundamental indicators, such as Operating Cycle, to predict how Ekso Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Operating Cycle 311.11  202.60 

Pair Trading with Ekso Bionics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Ekso Bionics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ekso Bionics will appreciate offsetting losses from the drop in the long position's value.

Moving against Ekso Stock

  0.78ELAB Elevai Labs CommonPairCorr
  0.66WOK WORK Medical TechnologyPairCorr
  0.65688656 HOB Biotech GroupPairCorr
  0.51300981 Zhonghong Pulin MedicalPairCorr
  0.44688198 Beijing Balance MedicalPairCorr
The ability to find closely correlated positions to Ekso Bionics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Ekso Bionics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Ekso Bionics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Ekso Bionics Holdings to buy it.
The correlation of Ekso Bionics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Ekso Bionics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Ekso Bionics Holdings moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Ekso Bionics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Ekso Bionics Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Ekso Bionics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ekso Bionics Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ekso Bionics Holdings Stock:
Check out the analysis of Ekso Bionics Correlation against competitors.
You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ekso Bionics. If investors know Ekso will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ekso Bionics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(5.38)
Revenue Per Share
7.246
Quarterly Revenue Growth
0.024
Return On Assets
(0.27)
Return On Equity
(0.85)
The market value of Ekso Bionics Holdings is measured differently than its book value, which is the value of Ekso that is recorded on the company's balance sheet. Investors also form their own opinion of Ekso Bionics' value that differs from its market value or its book value, called intrinsic value, which is Ekso Bionics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ekso Bionics' market value can be influenced by many factors that don't directly affect Ekso Bionics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ekso Bionics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Ekso Bionics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ekso Bionics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.